Egle Therapeutics
Company

Egle Therapeutics

Biotechnology Research Paris, Fr 48 employees
Employees
48
Contacts
2
Emails
2
Phones
1

Egle Therapeutics Overview

Headquarters
Paris, Fr
Website
www.egle-tx.com
Industry
Biotechnology Research
Employees
48
Founded
2020
Funding
10.1M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Egle Therapeutics

Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones.

Egle Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
1
25.0% coverage

Egle Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Christophe Quéva Innovation-driven Scientific Leader and Drug Developer
View
Pelletier Benjamin Research Engineer at Egle Therapeutics, Ph.d. in Immunology from Paris Saclay University
View
Stephen Lau Biotech C-suite Executive and Board Member - Entrepreneur - Focused on Fundraising & Deal-making - Company Formation
Email Phone
Michel Detheux Co-founder, President & CEO Iteos Therapeutics Inc
Email

Employees by Management Level

Individual contributor 3 profiles
Executive 1 profile

Egle Therapeutics Tech Stack

Engineering 2 profiles

Compare Similar Companies to Egle Therapeutics